Werfen Showcases Latest Innovations in Specialized Diagnostics
|
By LabMedica International staff writers Posted on 22 May 2023 |

Werfen (Barcelona, Spain) is participating in the 2023 WordLab-EuroMedLab Congress, the leading event in the field of laboratory medicine and clinical chemistry that brings together top experts and scientists from around the world. As a silver sponsor of the Congress, Werfen is welcoming visitors at La Nuvola Convention Center in Rome to its futuristic 80 square meters booth, ready to present its innovations in specialized diagnostics through its products and solutions.
Werfen provides advanced in vitro diagnostic solutions, catering to both point-of-care and lab testing needs. Its acute care diagnostic solutions address healthcare challenges across various healthcare settings, including cardiovascular operating rooms, catheterization labs, intensive care units, and emergency departments, improving efficiency and enhance patient care. At EuroMedLab Rome 2023, Werfen is highlighting its comprehensive and integrated line of acute care diagnostics. This includes the company’s blood gas family, featuring the GEM Premier and Avoximeter product lines, as well as the whole blood hemostasis family, featuring the ROTEM, Hemochron, and VerifyNow product lines.
As an active player in scientific knowledge, Werfen is promoting two educational sessions that will take place during the event. The first session titled 'Leveraging Innovative Technology to Optimize Quality in Point-of-Care Blood Gas Testing' will start by offering insights into the sources of preanalytical errors in point-of-care testing, followed by identification of the benefits of automated, continuous quality assurance vs. intermittent liquid quality control (QC). The speakers will identify strategies to address the risks of variability in sample collection, for enhanced patient safety and review the history of QC and novel Patient-Based, Real-Time QC. The session will conclude with a review of strategies to achieve higher quality standards with proactive tracking and monitoring of KPIs, using data management solutions.
The second session titled 'The value of experience in coagulation and autoimmunity. Werfen, Powering Patient Care' will focus on the value that automation and dedicated data management solutions, combined with the company's high specialization, can offer to laboratorians and clinicians, in Hemostasis and Autoimmunity, to ensure the best levels of patient care. In addition, the speaker will explain the organizational advantages of shortened turnaround time while increasing laboratory efficiency.
Werfen is also sponsoring the Satellite Meeting “Point-of-Care Testing: Home, Hospital and Beyond” - a forum for companies and industry experts to discuss topics around innovations and the future of POCT. In his talk “POC Organizational Models in the World and IT Solutions”, Davide Colombo, Global Acute Care Expert at Werfen, will share hospital organizational models and POC technology know-how in different countries, as well as explain the industry's role in the success of these organizations.
Related Links:
Werfen
Latest EUROMEDLAB 2023 News
- DIESSE Diagnostica Unveils CHORUS EVO Immunochemistry Analyzer
- LGC Clinical Diagnostics Demonstrates Lab Solutions and Processes to Enhance QC Efficiencies
- LumiraDx Demonstrates Fast, High Performance, Portable POC Diagnostic Solution
- Thermo Fisher Presents Latest Solutions in Laboratory Equipment and Technology
- Beckman Coulter Unveils New DxI 9000 Access Immunoassay Analyzer
- STAGO sthemO and sthemE Product Ranges Make World Premiere
- Sansure Biotech Demonstrates iPonatic III Portable Molecular Workstation
- Greiner Bio-One Presents Complete Concept of Digitalized Sample Collection Process
- BioPerfectus Showcases SAW-48 Automated Nucleic Acid Workstation
- Menarini Introduces PRIME MDx All-in-One Molecular Diagnostics Solution
- Binding Site Showcases Optilite System for Special Protein Testing
- Sebia Presents Innovative Solutions for Screening and Diagnostics
- DiaSorin Showcases Latest Assays and Reagents for In-Vitro Diagnostics
- Abbott Introduces GLP Systems Track Laboratory Automation Solution
- Randox Presents Future of Diagnostic Technology
- QuidelOrtho Highlights Innovative Point-of-Care Diagnostic Solutions
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreMolecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read moreAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channelNew Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more







 Analyzer.jpg)
